Wu Du
Senior Vice President Hinova Pharmaceuticals
Dr. Du received PhD in organic chemistry from the University of Pittsburgh. After postdoc in the Scripps Research Institute, he joined Merck, then later PTC Therapeutics as a medicinal chemist. Dr. Du delivered multiple small molecules, including inhibitors, agonist, oral PROTAC degraders, molecular glue degrader as PCCs and into clinical development. Currently he is SVP of medchem in Hinova Pharma.
Seminars
Wednesday 10th June 2026
Identification of Highly Potent & Selective VAV1 Molecular Glue Degrader HC118
4:30 pm
- Exploring how VAV1 is an emerging first in class target for autoimmune and chronic inflammatory indications
- Outlining how HC118 is an orally available molecular glue degrader that is highly potent and selective targeting VAV1
- Discovering how HC118 is highly efficacious in multiple animal models and demonstrated good preclinical safety profile
